Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Alcohol Use Disorder (RENEW-ALC-2)
A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Moderate-to-Severe Alcohol Use Disorder (RENEW-ALC-1)
A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors
Read the official source — NCT05574127Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors
A Study of Cannabidiol in Young Adult Cannabis Users
Read the official source — NCT06569394A Randomized, Placebo Controlled Study of Cannabidiol in Young Adult Cannabis Users
Home-based Transcranial Direct Current Stimulation in Bipolar Depression: a Randomised, Double-blind, Placebo-controlled Trial
Original registry wording; source language not specified.
A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Researchers are comparing NTX-1472 and placebo, tracking side effects to assess safety and tolerability in adults with an anxiety condition.
Researchers observe how olanzapine is used in routine care for people with bipolarity. They examine treatment patterns and whether education about weight gain is associated with less weight gain; the study does not assign or change treatment.
A pilot uncontrolled single arm non-randomised open-label trial of the acceptability and effect on motivation to quit and compliance with use of nicotine replacement therapy of supplying nicotine replacement therapies to smokers in community locations regardless of their motivation to quit smoking.
This study evaluates the safety and effectiveness of Seltorexant for people with depression.
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
Read the official source — NCT06655883Researchers are comparing Suvorexant and placebo, tracking side effects to assess safety in people with opioid dependence.
A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics Integrated Approach
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.